Insights

Small team agility Broadwing Bio is a very small biotechnology startup (2-10 employees) focusing on targeted antibody therapies for ophthalmic diseases, indicating a need for scalable capabilities, flexible partnerships, and outsized impact from efficient vendor and service providers.

Specialized ophthalmic focus The company concentrates on glaucoma and geographic atrophy, suggesting sales opportunities with suppliers of ophthalmology research tools, antibody development platforms, assay services, and specialized preclinical models aligned to eye diseases.

Genetically validated targets Their emphasis on genetically validated targets presents a market opening for gene-informed discovery platforms, genomic data services, collaboration with genetic data analytics firms, and partnerships that accelerate target validation and antibody engineering.

Partnership-driven origins Originating from Maze Therapeutics and Alloy Therapeutics, Broadwing Bio may be open to platform-based collaborations, outsourcing of discovery services, and joint development agreements that leverage external platforms and networks.

Moderate revenue, high potential Reported revenue range positions Broadwing as an early-stage signer for sponsored research, collaboration deals, or milestone-based licensing. Strategic outreach could focus on de-risked pilot programs, co-development, or contract research services to accelerate timelines.

Similar companies to Broadwing Bio

Broadwing Bio Tech Stack

Broadwing Bio uses 8 technology products and services including iCIMS, Cloudflare CDN, Cloudflare, and more. Explore Broadwing Bio's tech stack below.

  • Applicant Tracking Systems
  • Cloudflare CDN
    Content Delivery Network
  • Cloudflare
    Content Management System
  • Content Management System
  • Cloudflare DNS
    Domain Name Services
  • jQuery
    Javascript Libraries
  • Web Analytics

Broadwing Bio's Email Address Formats

Broadwing Bio uses at least 1 email format:
Broadwing Bio Email FormatsExamplePercentage
First.Last@broadwing.bioJohn.Doe@broadwing.bio
100%

Frequently Asked Questions

What is Broadwing Bio's official website and social media links?

Minus sign iconPlus sign icon
Broadwing Bio's official website is www.broadwing.bio and has social profiles on LinkedIn.

How much revenue does Broadwing Bio generate?

Minus sign iconPlus sign icon
As of September 2026, Broadwing Bio's annual revenue is estimated to be $1M - $10M.

What is Broadwing Bio's SIC code and NAICS code?

Minus sign iconPlus sign icon
Broadwing Bio's SIC code is 8731 - Commercial Physical and Biological Research and NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Broadwing Bio have currently?

Minus sign iconPlus sign icon
As of September 2026, Broadwing Bio has approximately 3 employees across 1 continents, including North America. Key team members include Co-Founder: M. R. and Board Member: A. D. Explore Broadwing Bio's employee directory with LeadIQ.

What industry does Broadwing Bio belong to?

Minus sign iconPlus sign icon
Broadwing Bio operates in the Biotechnology Research industry.

What technology does Broadwing Bio use?

Minus sign iconPlus sign icon
Broadwing Bio's tech stack includes iCIMS, Cloudflare CDN, Cloudflare, WordPress, Cloudflare DNS, Google Workspace, jQuery and Piwik PRO Core.

What is Broadwing Bio's email format?

Minus sign iconPlus sign icon
Broadwing Bio's email format typically follows the pattern of First.Last@broadwing.bio. Find more Broadwing Bio email formats with LeadIQ.
Broadwing Bio logo

Broadwing Bio

Biotechnology ResearchCalifornia, United States2-10 Employees

Broadwing Bio is a biotechnology research company focused on developing antibody therapies for eye diseases. It concentrates on targets supported by genetic validation with the aim of addressing glaucoma and geographic atrophy in patients. The company’s work centers on therapies intended to help preserve sight in those affected by these common causes of vision loss.

Based in South San Francisco, California, Broadwing Bio operates with a small team and maintains a website at broadwing.bio. The company began in 2020 through a collaboration between Maze Therapeutics and Alloy Therapeutics to pursue antibody-based therapies for eye diseases.

Section iconCompany Overview

SIC Code
8731 - Commercial Physical and Biological Research
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Employees
2-10

Section iconFunding & Financials

  • $1M - $10M

    Broadwing Bio's revenue is estimated to be in the range of $1M - $10M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.